The biggest pharmacy benefit managers are profiting by systematically underpaying independent drugstores, creating “pharmacy ...

Judge Karen Marston held that, despite plaintiffs' arguments to the contrary, marketing discovery is not relevant to the ...

Leerink Partnrs analyst D. Risinger now expects that the company will earn $1.24 per share for the quarter, […] ...

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and ...

IQ EQ FUND MANAGEMENT IRELAND Ltd boosted its stake in Eli Lilly and Company (NYSE:LLY – Free Report) by 4.8% during the 3rd quarter, according to its most recent 13F filing with the Securities and ...